Evidence map›Paper›PMID 40853975›Full record

ArticlePLoS neglected tropical diseases2025

Remapping parasite landscapes: Nationwide prevalence, intensity and risk factors of schistosomiasis and soil-transmitted helminthiasis in Rwanda.

Ladislas Nshimiyimana, Jean Bosco Mbonigaba, Aimable Mbituyumuremyi, Alison Ower, Dieudonne Hakizimana, Elias Nyandwi, Karen Palacio, Alphonse Mutabazi, Jeanne Uwizeyimana, Leonard Uwayezu and 17 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Ladislas NshimiyimanaDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.ORCID 0000-0002-5551-6990
Jean Bosco MbonigabaDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Aimable MbituyumuremyiDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Alison OwerThe END Fund, New York, United States of America.
Dieudonne HakizimanaDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-5379-4129
Elias NyandwiCentre for Geographic Information Systems and Remote Sensing (CGIS - UR), College of Sciences and Technology, University of Rwanda, Kigali, Rwanda.
Karen PalacioThe END Fund, New York, United States of America.
Alphonse MutabaziDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Jeanne UwizeyimanaHeart and Sole Africa, Kigali, Rwanda.
Leonard UwayezuByumba Level Two Teaching Hospital, Gicumbi, Rwanda.
Michee KaberaDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Emmanuel HakizimanaDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Phocas MazimpakaDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Emmanuel RuzindanaNational Reference Laboratory (NRL) Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Eliah ShemaSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Tharcisse MunyanezaNational Reference Laboratory (NRL) Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Jean Bosco MucacaNational Reference Laboratory (NRL) Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Maurice TwahirwaNational Reference Laboratory (NRL) Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Esperance UmumararunguNational Reference Laboratory (NRL) Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Joseph KagaboSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Richard HabimanaSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Elias NiyitumaDivision of Malaria and Other Parasitic Diseases, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Tonya HustonHeart and Sole Africa, Kigali, Rwanda.
Jamie TallantThe END Fund, New York, United States of America.
Warren LancasterThe END Fund, New York, United States of America.
Nadine RujeniSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Eugene RuberanzizaThe END Fund, New York, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSoil-transmitted helminthiasis (STH) and schistosomiasis (SCH) remain significant public health challenges in Rwanda, affecting individuals across all age groups. Despite ongoing mass drug administration (MDA) efforts, updated data on prevalence and risk factors are crucial for effective control and elimination strategies. This study reassessed the prevalence of STH and SCH in both children and adults in Rwanda, along with their associated risk factors, to guide control efforts. METHODOLOGY: A nationwide survey was conducted across 30 districts, testing 17,360 individuals for STH and 17,342 for Schistosoma mansoni using Kato-Katz (KK) and Point-Of-Care Circulating Cathodic Antigen (POC-CCA) tests. Mixed-effects logistic regression models were used to identify risk factors while accounting for district-level variability.

findingsThe overall prevalence of STH was 38.7% (95% CI: 37.9-39.4), highest among adults (46.1%, 95% CI: 44.8-47.3) and lowest among preschool-aged children (30.2%, 95% CI: 29.0-31.5). Species-specific prevalence was 27.0% for Ascaris lumbricoides (95% CI: 26.3-27.6), 11.6% for Trichuris trichiura (95% CI: 11.2-12.1), and 10.7% for hookworm (95% CI: 10.3-11.2). Moderate-to-heavy intensity (MHI) infections were detected in 8.1% of Ascaris lumbricoides (95% CI: 7.7-8.5), 0.8% of Trichuris trichiura (95% CI: 0.6-0.9), and 0.1% of hookworm (95% CI: 0-0.2). SCH prevalence was 1.7% (95% CI: 1.5-1.9) by KK and 27.2% (95% CI: 26.5-27.9) when trace results on POC-CCA were considered positive. Heavy Schistosoma mansoni infections were rare (0.1%, 95% CI: 0-0.1). Mixed-effects logistic regression (p < 0.05) showed that for STH, higher odds were associated with being single (AOR: 1.74), no education (AOR: 1.56), use of human excreta as manure (AOR: 1.43), unimproved water sources (AOR: 1.17), and proximity to marshlands (AOR: 1.17). Lower odds were seen among those with higher education (AOR: 0.55), unemployed (AOR: 0.34), self-employed or retired (AOR: 0.53), students (AOR: 0.54), those with deep toilets (AOR: 0.78), and those treating water consistently (AOR: 0.79). For SCH, higher odds were linked to being single (AOR: 1.61), no education (AOR: 1.41), proximity to lakes (AOR: 1.76) or rice fields (AOR: 1.31), use of treated (AOR: 1.32) or untreated (AOR: 1.60) excreta as manure, and living over an hour from a water source (AOR: 1.42).

conclusionSTH and SCH remain significant public health challenges in Rwanda, with certain regions and population groups still exceeding the elimination threshold as public health problems. Expanding MDA programs to include adults, improving sanitation and hygiene, ensuring universal access to clean water, and promoting community education on safe practices are essential for achieving sustainable control and elimination of these infections.

Indexed as

HelminthiasisSchistosomiasis mansoniSoilAdolescentAdultAgedAnimalsChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedPrevalenceRisk FactorsSoil

Identifiers

PMID40853975
PMCPMC12377619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.